{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T22:29:52Z","timestamp":1649024992297},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s15006-012-0934-1","type":"journal-article","created":{"date-parts":[[2012,7,30]],"date-time":"2012-07-30T08:09:20Z","timestamp":1343635760000},"page":"76-79","source":"Crossref","is-referenced-by-count":0,"title":["Wann lokal, wann systemisch wann operativ behandeln?"],"prefix":"10.1007","volume":"154","author":[{"given":"Raja","family":"Atreya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"Neurath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,31]]},"reference":[{"key":"934_CR1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"S.C. Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955; 2: 1041\u20131048.","journal-title":"Br Med J"},{"key":"934_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/gut.4.4.299","volume":"4","author":"F.C. Edwards","year":"1963","unstructured":"Edwards FC, Truelove SC. The Course And Prognosis Of Ulcerative Colitis. Gut 1963; 4: 299\u2013315.","journal-title":"Gut"},{"key":"934_CR3","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1055\/s-0031-1281666","volume":"49","author":"A. Dignass","year":"2011","unstructured":"Dignass A, Preiss JC, Aust DE et al. [Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011]. Z Gastroenterol. 2011; 49: 1276\u2013341.","journal-title":"Z Gastroenterol."},{"key":"934_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.crohns.2007.11.002","volume":"2","author":"S.P. Travis","year":"2008","unstructured":"Travis SP, Stange EF, L\u00e9mann M et al. for the European Crohn\u2019s and Colitis Organisation (ECCO). European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis. 2008; 2: 24\u201362.","journal-title":"J Crohns Colitis."},{"key":"934_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2036.1995.tb00384.x","volume":"9","author":"J.K. Marshall","year":"1995","unstructured":"Marshall JK, Irvine EJ. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 1995; 9: 293\u2013300.","journal-title":"Aliment Pharmacol Ther"},{"key":"934_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3109\/00365529008997590","volume":"25","author":"M. Campieri","year":"1990","unstructured":"Campieri M, De Franchis R, Bianchi Porro G et al. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial. Scandinavian Journal of Gastroenterology 1990; 25: 663\u2013668.","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"934_CR7","first-page":"1867","volume":"92","author":"M. Safdi","year":"1997","unstructured":"Safdi M, DeMicco M, Sninsky C et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. The American Journal of Gastroenterology 1997; 92: 1867\u20131871.","journal-title":"The American Journal of Gastroenterology"},{"key":"934_CR8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/gut.2008.154302","volume":"58","author":"W. Kruis","year":"2009","unstructured":"Kruis W, Kiudelis G, Racz I et al. Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial. Gut 2009; 58: 233\u2013240.","journal-title":"Gut"},{"key":"934_CR9","doi-asserted-by":"crossref","unstructured":"Lichtiger S, Present DH, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. The New England Journal of Medicine 1994: 1841\u20131845.","DOI":"10.1056\/NEJM199406303302601"},{"key":"934_CR10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/gut.2005.081794","volume":"55","author":"H. Ogata","year":"2006","unstructured":"Ogata H, Matsui T, Nakamura M et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 2006; 55: 1255\u20131262.","journal-title":"Gut"},{"key":"934_CR11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/gut.2010.221127","volume":"60","author":"W. Reinisch","year":"2011","unstructured":"Reinisch W, Sandborn WJ, Hommes DW, D\u2019Haens G, Hanauer S, Schreiber S, Panaccione R, Fedorak RN, Tighe MB, Huang B, Kampman W, Lazar A, Thakkar R. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut. 2011; 60: 780\u2013787.","journal-title":"Gut"},{"key":"934_CR12","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1053\/j.gastro.2005.03.003","volume":"128","author":"G. J\u00e4rnerot","year":"2005","unstructured":"J\u00e4rnerot G, Hertervig E, Friis-Liby I et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128: 1805\u20131811.","journal-title":"Gastroenterology"},{"key":"934_CR13","doi-asserted-by":"crossref","unstructured":"Neurath, Travis. Mucosal healing in IBD. A systematic review. Gut 2012 [in press].","DOI":"10.1136\/gutjnl-2012-302830"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-012-0934-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15006-012-0934-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-012-0934-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T10:36:10Z","timestamp":1600857370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-012-0934-1"}},"subtitle":["Rationale Therapie der Colitis ulcerosa"],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":13,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1007\/s15006-012-0934-1","relation":{},"ISSN":["1438-3276"],"issn-type":[{"value":"1438-3276","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}